Corporate Support
Sitemap

Features

Customer Services

Events

Terms of Use

Singapore
Malaysia

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,581.3
-14.7 (-0.56%)

 

  • STI Straits Times Index
    2,581.3
    -14.7 (-0.56%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,564.6
    -11.8 (-0.75%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,183.0
    -47.7 (-0.19%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,360.1
    39.4 (1.19%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,289.4
    39.8 (0.17%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,247.7
    8.4 (0.16%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,818.9M
  • Value: 1,195.1M
  • Rise: 145
  • Fall: 205
  • Unch: 458

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol

  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.036-
Yinda Infocomm0.035-
Rex Intl0.168-0.013
ChinaKundaTech0.028+0.002
FJ Benjamin^0.020+0.002
Singapore-eDev0.062-0.012
Medtecs Intl1.610+0.050
ThaiBev0.605-
Kitchen Culture0.215-0.105
AnAn Intl0.037-

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,265.5 -284.5
HSCEI 9,743.2 -110.0
Jakarta 4,863.1 -41.0
Nikkei 225 22,047.8 -464.2
SSE Comp 2,960.5 -10.1
Shanghai A 3,103.1 -10.6
Shanghai B 211.8 -1.7
KOSPI 2,097.3 -37.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help

  • Factsheet

  • Print

CONTANGO ASSET MANAGEMENT LIMITED CONTANGO ASSET MANAGEMENT
Updated on 14 Aug 2020 (End of trading day)
Last (AUD): 0.380 Change: - High: 0.380 Remarks: -
Change (%): - Low: 0.380
Open 0.380 Yesterday's Close 0.38
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) - Cumulative Value
 
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.11018 Trailing EPS (AUD) e -0.08562 NAV (AUD) b 0.2136
PE a - Trailing PE f - Price / NAV b 1.7790
Dividend (AUD) d - Cash In Hand (AUD) g 0.0581 Issued & Paid-up Shares c 47,278,800
Dividend Yield (%) d - Price / Cash In Hand g 6.540 Treasury Shares h -
Beta - 75 Daysi 0.313 R-Squared - 75 Days(%)i 0.47 Market Cap (M) 17.966
Beta - 500 Daysi -0.043 R-Squared - 500 Days (%)i 0.01 Enterprise Value (M) 16.469
Piotroski F Score 0 Exchange Code CGA Par Value ( AUD ) n.a.
52 Weeks Volatility (%) 55.88 Free Float (%) -
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 28 Jun 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 08 Sep 2016.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CONTANGO ASSET MANAGEMENT LIMITED ASX 17.966 - - 1.7790 -
Industry Biotechnology ASX 3,599.407 56.473 51.169 13.5438 0.904
Local Peer CSL ASX 126,834.048 47.275 43.784 14.6656 0.950
Local Peer MESOBLAST LTD ASX 2,730.404 - - 3.4259 -
Local Peer POLYNOVO LIMITED ASX 1,480.837 - - 60.3774 -
Local Peer TELIX PHARMACEUTIC ASX 344.094 - - 4.9094 -
Local Peer NEXT SCIENCE LTD ASX 252.350 - - 9.1628 -
Local Peer IMUGENE LIMITED ASX 250.084 - - 3.8356 -
Local Peer NEUREN PHARMACEUTICALS LTD ASX 149.950 - - 10.8326 -
Local Peer MEMPHASYS LTD ASX 116.866 - - 11.7424 -
Local Peer ANTEOTECH LIMITED ASX 90.346 - - 28.4211 -
Local Peer IMMUTEP LTD ASX 87.774 - - 3.1304 -
Local Peer GENETIC TECHNOLOGIES ASX 82.617 - - 33.3333 -
Local Peer KAZIA THERAPEUTICS LIMITED ASX 79.463 - - 6.4815 -
Other Local Peers CYNATA THERAPEUTICS LTD (ASX), INVEX THERAPEUTICS LTD NPV (ASX), BIOTRON (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), BIONOMICS LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), REGENEUS LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), ADALTA LTD (ASX), RHINOMED LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), PATRYS LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), CRYOSITE (ASX), ANATARA LIFESCIENCES LTD (ASX), LEAF RESOURCES LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), NANOLLOSE LTD (ASX)
Global Peer AMGEN INC NASDAQ 140,396.709 17.903 19.235 13.1717 2.443
Global Peer GILEAD SCIENCES INC NASDAQ 85,879.820 15.945 - 4.7640 3.715
Global Peer AMGEN-T HKEx 585,694.000 9.532 10.295 7.0897 4.589
Global Peer VERTEX PHARMACEUTICAL NASDAQ 69,620.224 59.160 33.459 9.2589 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 65,172.529 30.803 21.844 7.1955 -
Global Peer ILLUMINA INC NASDAQ 50,743.760 50.643 73.223 11.1207 -
Global Peer BIOGEN INC NASDAQ 45,823.698 7.782 7.732 4.0521 -
Global Peer WUXI BIO HKEx 216,907.105 188.686 188.685 15.1677 -
Global Peer SEATTLE GENETICS INC NASDAQ 27,364.508 - - 15.0845 -
Global Peer MODERNA INC NASDAQ 27,285.691 - - 9.2591 -
Other Global Peers ALEXION PHARMACEUTICAL INC (NASDAQ), SINO BIOPHARM (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), INCYTE CORPORATION (NASDAQ), BEIGENE (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NOVAVAX INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), EXELIXIS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ACCELERON PHARMA (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), Lonza (SGX), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), GENSCRIPT BIO (HKEx), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), 3SBIO (HKEx), SORRENTO THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), ALKERMES PLC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), VAXCYTE INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ALLOVIR INC (NASDAQ), VIVA BIOTECH (HKEx), HAOHAI BIOTEC (HKEx), EDITAS MEDICINE INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), SERES THERAPEUTICS (NASDAQ), VIELA BIO INC (NASDAQ), ALPHAMAB-B (HKEx), VERACYTE INC (NASDAQ), XENCOR INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), UNIQURE N.V. (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), MYOVANT SCIENCES LTD (NYSE), ROCKET PHARMACEUTICALS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), MACROGENICS INC (NASDAQ), COMPUGEN (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), CORTEXYME INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), EPIZYME INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), REGENXBIO INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), ASCENTAGE-B (HKEx), ITEOS THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), VAXART INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), FRONTAGE (HKEx), STOKE THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), RETROPHIN INC (NASDAQ), NKARTA INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), OMEROS CORP (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), PERSONALIS INC (NASDAQ), PRECIGEN INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), KINTOR PHARMA-B (HKEx), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), KADMON HLDGS INC (NYSE), AKOUOS INC (NASDAQ), AGENUS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), IMMUNOGEN INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), IMMATICS N V (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), UROGEN PHARMA LTD (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), ARDELYX INC (NASDAQ), XBIOTECH INC (NASDAQ), DPHARMA (Bursa), PROTHENA CORP PLC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), ATHERSYS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), SINOMAB BIO-B (HKEx), KAMADA (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), LEE'S PHARM (HKEx), ASCLETIS-B (HKEx), IVERIC BIO INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), MERUS B V (NASDAQ), ESSEX BIO-TECH (HKEx), MANNKIND CORPORATION (NASDAQ), NANOVIRICIDES INC (NYSE American), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), TREVENA INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), PRECISION BIOSCIENCES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), PFENEX INC (NYSE American), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), IMV INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), CABALETTA BIO INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), CHIASMA INC (NASDAQ), AFFIMED N V (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), NEXTCURE INC (NASDAQ), VERASTEM INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), IBIO INC (NYSE American), CASI PHARMACEUTICALS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), XOMA CORP (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), ADURO BIOTECH INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), CHIMERIX INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), CONTRAFECT CORP (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), EQUILLIUM INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), AVALON GLOBOCARE CORP (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), INMUNE BIO INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ORGENESIS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), SESEN BIO INC (NASDAQ), VACCINEX INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), CEL-SCI CORP (NYSE American), SIERRA ONCOLOGY INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), INFLARX N V (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), UNI-BIO GROUP (HKEx), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), ARAVIVE INC (NASDAQ), SAVARA INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), DIAMEDICA THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), SYNLOGIC INC (NASDAQ), RESTORBIO INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), OCUGEN INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), RECRO PHARMA INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), CURIS INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), COHBAR INC (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), ANIXA BIOSCIENCES INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), SOLIGENIX INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), SUNESIS PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), CT ENTERPRISE (HKEx), SEELOS THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ORAGENICS INC (NYSE American), PULMATRIX INCORPORATED (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ATYR PHARMA INC (NASDAQ), EVOGENE LTD (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ADVAXIS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), BIOSINO BIO-TEC (HKEx), AIKIDO PHARMA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), BIOCARDIA INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), Suntar Eco-City (SGX), ADITX THERAPEUTICS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), REGENT PACIFIC (HKEx), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), TRACON PHARMACEUTICALS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), SENESTECH INC (NASDAQ), HAO WEN HLDGS (HKEx), AURIS MEDICAL HOLDING LTD (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days ---
10 Days ---
20 Days -+0.100
+35.71 %
Medium Term Return 3 Months -+0.130
+52.00 %
6 Months --0.060
-13.64 %
1 Year --0.070
-15.56 %
Long Term Return 2 Years --0.255
-40.16 %
3 Years --0.520
-57.78 %
Annualised Return Annualised --
-24.98 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.250 - 0.490 Change From 1 Year Low +0.130 % Change From 1 Year Low (%) +52.00
Change From 1 Year High -0.110 % Change From 1 Year High (%) -22.45
2 Years Range 0.215 - 0.700 Change From 2 Years Low +0.165 % Change From 2 Years Low (%) +76.74
Change From 2 Years High -0.320 % Change From 2 Years High (%) -45.71
5 Years Range 0.215 - 1.930 Change From 5 Years Low +0.165 % Change From 5 Years Low (%) +76.74
Change From 5 Years High -1.550 % Change From 5 Years High (%) -80.31
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Contango Asset Management Ltd. engages in the provision of asset management services. It manages ASX ex-30 dividend income strategy, Contango Income Generator Limited, and the large cap global ex-Australia growth strategy, Contango Global Growth Limited. The company was founded on December 21, 1998 and is headquartered in Sydney, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
14 Aug 2020 0.380 0.380 0.380 0.380 - -
13 Aug 2020 0.380 0.380 0.380 0.380 - -
12 Aug 2020 0.380 0.380 0.380 0.380 - -
11 Aug 2020 0.380 0.380 0.380 0.380 - -
10 Aug 2020 0.380 0.380 0.380 0.380 - -
07 Aug 2020 0.380 0.380 0.380 0.380 - -
06 Aug 2020 0.380 0.380 0.380 0.380 - -
05 Aug 2020 0.380 0.380 0.380 0.380 - -
04 Aug 2020 0.380 0.380 0.380 0.380 - -
03 Aug 2020 0.380 0.380 0.380 0.380 - -
31 Jul 2020 0.380 0.380 0.380 0.380 - -
30 Jul 2020 0.380 0.380 0.380 0.380 5,000 -
29 Jul 2020 0.360 0.360 0.360 0.360 - -
28 Jul 2020 0.360 0.360 0.360 0.360 - -
27 Jul 2020 0.360 0.360 0.360 0.360 30,000 -
24 Jul 2020 0.340 0.340 0.340 0.340 - -
23 Jul 2020 0.340 0.340 0.340 0.340 30,000 -
22 Jul 2020 0.300 0.300 0.300 0.300 - -
21 Jul 2020 0.300 0.300 0.300 0.300 - -
20 Jul 2020 0.300 0.300 0.300 0.300 30,000 -
17 Jul 2020 0.280 0.280 0.280 0.280 - -
16 Jul 2020 0.340 0.340 0.280 0.280 51,800 -
Summary
Current 2 Weeks
(03 Aug 2020 to 14 Aug 2020)		 0.380 0.380 0.380 0.380 - -
Previous 2 Weeks
(20 Jul 2020 to 31 Jul 2020)		 0.300 0.380 0.300 0.380 95,000 -
4 Weeks from
(19 Jun 2020 to 17 Jul 2020)		 0.280 0.380 0.280 0.280 146,596 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.